Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex
Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporte...
Gespeichert in:
Veröffentlicht in: | Synapse (New York, N.Y.) N.Y.), 2004-07, Vol.53 (1), p.44-52 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 52 |
---|---|
container_issue | 1 |
container_start_page | 44 |
container_title | Synapse (New York, N.Y.) |
container_volume | 53 |
creator | Pan, Wynn H.T. Yang, Sze-Yuan Lin, Shi-Kwang |
description | Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/syn.20034 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71951557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71951557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</originalsourceid><addsrcrecordid>eNp1kE1PGzEQhq0KVALl0D-A9oTUw8J4_bV7rFAbkGg40Ao4WbZ30pjueoO9UZp_X0NSOHHyaPS8jzwvIZ8pnFGA6jxtwlkFwPgHMqHQ1GXFGrlHJlDXquRcyQNymNIjZIQC_0gOqKACFIcJWcxwFQe3wN470xU-jBiNG_0QCovjGjEU7bA0vQ8Yf3tXmNAWYYimjbjbhGdBSDlajAssemx9Fi0jzvN6zKMb4oh_P5H9uekSHu_eI_Lr-7efF5fl9c306uLrdem4AF6yWoGtJZMOBOPADGWGV9aCbKlCy-dgjJOSCtU4UVVgWSVri1ZAbbkBZEfkdOtdxuFphWnUvU8Ou84EHFZJK9rk44XK4Jct6OKQUv6uXkbfm7jRFPRzrTrXql9qzezJTrqy-cA3ctdjBs63wNp3uHnfpG8fZv-V5TbhU27nNWHiHy0VU0Lfzaa6YT-m04bfa2D_AI9Ekf0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71951557</pqid></control><display><type>article</type><title>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Pan, Wynn H.T. ; Yang, Sze-Yuan ; Lin, Shi-Kwang</creator><creatorcontrib>Pan, Wynn H.T. ; Yang, Sze-Yuan ; Lin, Shi-Kwang</creatorcontrib><description>Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-4476</identifier><identifier>EISSN: 1098-2396</identifier><identifier>DOI: 10.1002/syn.20034</identifier><identifier>PMID: 15150740</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adrenergic alpha-Agonists - administration & dosage ; Adrenergic alpha-Antagonists - administration & dosage ; Animals ; catecholamine ; Dopamine - administration & dosage ; Dopamine - metabolism ; Dopamine Antagonists - administration & dosage ; frontal cortex ; Injections, Intraventricular ; Male ; Microdialysis ; Neurons - drug effects ; Neurons - metabolism ; neurotransmission ; Norepinephrine - administration & dosage ; Norepinephrine - metabolism ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Rats ; Rats, Sprague-Dawley ; Receptors, Adrenergic, alpha-1 - metabolism ; Receptors, Adrenergic, alpha-2 - metabolism ; Receptors, Dopamine D1 - metabolism ; Receptors, Dopamine D2 - metabolism</subject><ispartof>Synapse (New York, N.Y.), 2004-07, Vol.53 (1), p.44-52</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>Copyright 2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</citedby><cites>FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fsyn.20034$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fsyn.20034$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15150740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Wynn H.T.</creatorcontrib><creatorcontrib>Yang, Sze-Yuan</creatorcontrib><creatorcontrib>Lin, Shi-Kwang</creatorcontrib><title>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</title><title>Synapse (New York, N.Y.)</title><addtitle>Synapse</addtitle><description>Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc.</description><subject>Adrenergic alpha-Agonists - administration & dosage</subject><subject>Adrenergic alpha-Antagonists - administration & dosage</subject><subject>Animals</subject><subject>catecholamine</subject><subject>Dopamine - administration & dosage</subject><subject>Dopamine - metabolism</subject><subject>Dopamine Antagonists - administration & dosage</subject><subject>frontal cortex</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Microdialysis</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>neurotransmission</subject><subject>Norepinephrine - administration & dosage</subject><subject>Norepinephrine - metabolism</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Adrenergic, alpha-1 - metabolism</subject><subject>Receptors, Adrenergic, alpha-2 - metabolism</subject><subject>Receptors, Dopamine D1 - metabolism</subject><subject>Receptors, Dopamine D2 - metabolism</subject><issn>0887-4476</issn><issn>1098-2396</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PGzEQhq0KVALl0D-A9oTUw8J4_bV7rFAbkGg40Ao4WbZ30pjueoO9UZp_X0NSOHHyaPS8jzwvIZ8pnFGA6jxtwlkFwPgHMqHQ1GXFGrlHJlDXquRcyQNymNIjZIQC_0gOqKACFIcJWcxwFQe3wN470xU-jBiNG_0QCovjGjEU7bA0vQ8Yf3tXmNAWYYimjbjbhGdBSDlajAssemx9Fi0jzvN6zKMb4oh_P5H9uekSHu_eI_Lr-7efF5fl9c306uLrdem4AF6yWoGtJZMOBOPADGWGV9aCbKlCy-dgjJOSCtU4UVVgWSVri1ZAbbkBZEfkdOtdxuFphWnUvU8Ou84EHFZJK9rk44XK4Jct6OKQUv6uXkbfm7jRFPRzrTrXql9qzezJTrqy-cA3ctdjBs63wNp3uHnfpG8fZv-V5TbhU27nNWHiHy0VU0Lfzaa6YT-m04bfa2D_AI9Ekf0</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Pan, Wynn H.T.</creator><creator>Yang, Sze-Yuan</creator><creator>Lin, Shi-Kwang</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</title><author>Pan, Wynn H.T. ; Yang, Sze-Yuan ; Lin, Shi-Kwang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adrenergic alpha-Agonists - administration & dosage</topic><topic>Adrenergic alpha-Antagonists - administration & dosage</topic><topic>Animals</topic><topic>catecholamine</topic><topic>Dopamine - administration & dosage</topic><topic>Dopamine - metabolism</topic><topic>Dopamine Antagonists - administration & dosage</topic><topic>frontal cortex</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Microdialysis</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>neurotransmission</topic><topic>Norepinephrine - administration & dosage</topic><topic>Norepinephrine - metabolism</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Adrenergic, alpha-1 - metabolism</topic><topic>Receptors, Adrenergic, alpha-2 - metabolism</topic><topic>Receptors, Dopamine D1 - metabolism</topic><topic>Receptors, Dopamine D2 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Wynn H.T.</creatorcontrib><creatorcontrib>Yang, Sze-Yuan</creatorcontrib><creatorcontrib>Lin, Shi-Kwang</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Synapse (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Wynn H.T.</au><au>Yang, Sze-Yuan</au><au>Lin, Shi-Kwang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</atitle><jtitle>Synapse (New York, N.Y.)</jtitle><addtitle>Synapse</addtitle><date>2004-07</date><risdate>2004</risdate><volume>53</volume><issue>1</issue><spage>44</spage><epage>52</epage><pages>44-52</pages><issn>0887-4476</issn><eissn>1098-2396</eissn><abstract>Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15150740</pmid><doi>10.1002/syn.20034</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0887-4476 |
ispartof | Synapse (New York, N.Y.), 2004-07, Vol.53 (1), p.44-52 |
issn | 0887-4476 1098-2396 |
language | eng |
recordid | cdi_proquest_miscellaneous_71951557 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Adrenergic alpha-Agonists - administration & dosage Adrenergic alpha-Antagonists - administration & dosage Animals catecholamine Dopamine - administration & dosage Dopamine - metabolism Dopamine Antagonists - administration & dosage frontal cortex Injections, Intraventricular Male Microdialysis Neurons - drug effects Neurons - metabolism neurotransmission Norepinephrine - administration & dosage Norepinephrine - metabolism Prefrontal Cortex - drug effects Prefrontal Cortex - metabolism Rats Rats, Sprague-Dawley Receptors, Adrenergic, alpha-1 - metabolism Receptors, Adrenergic, alpha-2 - metabolism Receptors, Dopamine D1 - metabolism Receptors, Dopamine D2 - metabolism |
title | Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A51%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurochemical%20interaction%20between%20dopaminergic%20and%20noradrenergic%20neurons%20in%20the%20medial%20prefrontal%20cortex&rft.jtitle=Synapse%20(New%20York,%20N.Y.)&rft.au=Pan,%20Wynn%20H.T.&rft.date=2004-07&rft.volume=53&rft.issue=1&rft.spage=44&rft.epage=52&rft.pages=44-52&rft.issn=0887-4476&rft.eissn=1098-2396&rft_id=info:doi/10.1002/syn.20034&rft_dat=%3Cproquest_cross%3E71951557%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71951557&rft_id=info:pmid/15150740&rfr_iscdi=true |